Use of Affimer technology for inhibition of α2-antiplasmin and enhancement of fibrinolysis.
Pechlivani N, Alsayejh B, Almutairi M, Simmons K, Gaule T, Phoenix F, Kietsiriroje N, Ponnambalam S, Duval C, Ariëns RAS, Tiede C, Tomlinson DC, Ajjan RA.
Pechlivani N, et al. Among authors: duval c.
Blood Adv. 2025 Jan 14;9(1):89-100. doi: 10.1182/bloodadvances.2024014235.
Blood Adv. 2025.
PMID: 39504559
Free article.